Literature DB >> 31203506

Outcomes of endoscopic orbital decompression for graves' ophthalmopathy.

Robbie S R Woods1, Qistina Pilson2, Natallia Kharytaniuk3, Lorraine Cassidy2, Rizwana Khan2, Conrad V I Timon3.   

Abstract

BACKGROUND/AIMS: We assess outcomes of endoscopic orbital decompression for Graves' ophthalmopathy.
METHODS: A review of endoscopic orbital decompressions of the medial and partial inferior wall between July 2004 and July 2017 was carried out. Outcome was assessed by comparing pre- and post-operative measurements of exophthalmometry and visual acuity. Results were evaluated by repeated measures analysis of variance.
RESULTS: A total of 41 orbits in 25 patients underwent endoscopic orbital decompression for Graves' ophthalmopathy in the time period; however, six orbits in three patients had insufficient data for inclusion. Eleven patients required concurrent septoplasty to allow access. Measurements were taken at a mean of 11 days, 32 days, and 95 days post-operatively. Reduction in mean proptosis was 2.81 mm at 1-month post-decompression and 3.26 mm at 3 months. There was no significant difference between those treated for compressive optic neuropathy compared with those treated for cosmetic reasons. Colour vision by Ishihara plate improved significantly by a mean score of 2.67 post-operatively. Using LogMAR conversion for visual acuity, measured by a best-corrected Snellen chart, improvement of 0.18 was achieved at 1-month post-decompression, equivalent to approximately two lines on the Snellen chart. There was minimal (0.04) further improvement at 3 months. The improvement in visual acuity was greater in cases treated for compressive optic neuropathy than cosmesis, but this did not reach statistical significance (p = 0.06). Three cases required revision surgery. Diplopia disimproved or developed in four cases and squint surgery was required in three cases.
CONCLUSIONS: Endoscopic orbital decompression offers an effective, safe and minimally invasive treatment for Graves' ophthalmopathy. There is a trend towards continued improvement in outcomes over the course of 3 months post-operatively.

Entities:  

Keywords:  Cosmesis; Endoscopic surgery; Graves’ ophthalmopathy; Optic nerve; Orbital decompression

Mesh:

Year:  2019        PMID: 31203506     DOI: 10.1007/s11845-019-02043-2

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  26 in total

Review 1.  Surgical orbital decompression for thyroid eye disease.

Authors:  Kostas G Boboridis; Catey Bunce
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Endoscopic transnasal orbital decompression.

Authors:  D W Kennedy; M L Goodstein; N R Miller; S J Zinreich
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-03

3.  Orbital decompression for the management of thyroid eye disease: An analysis of outcomes and complications.

Authors:  Todd T Kingdom; Brett W Davies; Vikram D Durairaj
Journal:  Laryngoscope       Date:  2015-04-17       Impact factor: 3.325

4.  Course of proptosis in patients with Graves' disease after endoscopic orbital decompression.

Authors:  S O Ulualp; B M Massaro; R J Toohill
Journal:  Laryngoscope       Date:  1999-08       Impact factor: 3.325

5.  Long-term follow-up of patients with thyroid eye disease treated with endoscopic orbital decompression.

Authors:  Shashi Gulati; Hans Olav Ueland; Olav H Haugen; Arild Danielsen; Eyvind Rødahl
Journal:  Acta Ophthalmol       Date:  2014-07-02       Impact factor: 3.761

6.  Endoscopic medial orbital fat decompression for proptosis in type 1 graves orbitopathy.

Authors:  Wencan Wu; Dinesh Selva; Yang Bian; Xiaopeng Wang; Michelle T Sun; Qiao Kong; Wentao Yan
Journal:  Am J Ophthalmol       Date:  2014-11-01       Impact factor: 5.258

7.  Medial and lateral orbital wall surgery for balanced decompression in thyroid eye disease.

Authors:  Scott M Graham; Christopher L Brown; Keith D Carter; Alice Song; Jeffrey A Nerad
Journal:  Laryngoscope       Date:  2003-07       Impact factor: 3.325

Review 8.  Outcomes following surgical decompression for dysthyroid orbitopathy (Graves' disease).

Authors:  Samuel C Leong; Paul S White
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-02       Impact factor: 2.064

Review 9.  Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.

Authors:  Wilmar M Wiersinga
Journal:  Lancet Diabetes Endocrinol       Date:  2016-06-23       Impact factor: 32.069

10.  Thyroid-Related Orbital Decompression Surgery: A Multivariate Analysis of Risk Factors and Outcomes.

Authors:  Chris Y Wu; Leslie M Niziol; David C Musch; Alon Kahana
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2017 May/Jun       Impact factor: 1.746

View more
  2 in total

1.  Endoscopic Orbital Decompression for Graves' Orbitopathy - A Vietnam Study.

Authors:  Thi My Hanh Pham; Chien Thang Nguyen; Quoc Tung Mai; Thi Huong Giang Bui; Dung Hoa Do; Peter McCluskey; Trong Van Pham
Journal:  Clin Ophthalmol       Date:  2021-04-22

2.  Transnasal Endoscopic Orbital Decompression Combined with an Enhanced Recovery after Surgery Protocol in Graves Ophthalmopathy.

Authors:  Hui-Qing Xu; Qian Wang; Li-Li Hu; Hong Li; Feng Peng
Journal:  J Ophthalmol       Date:  2022-09-16       Impact factor: 1.974

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.